Hi! Our 2nd Annual Biopharma Comms Forum is just two months away. This year’s theme, Clarity at the Flashpoint, focuses on how biopharma communicators can operate when uncertainty is the norm rather than the exception. We have a full-day agenda planned that spans the biggest issues our community is facing. We'll discuss navigating AI disruption, how we can strengthen trust in science when skepticism is rising, and how to maintain influence when organizations are under pressure. Second Annual...
4 days ago • 1 min read
Hi! Burnout among biopharma communicators is widespread and getting harder to ignore. Many of us operate in high-stakes, always-on environments where the expectation to be responsive never fully turns off. While resilience and self-care get a lot of attention, the real drivers of burnout can be found in unclear processes that create unnecessary work, workloads that outpace resources, and cultures that reward constant availability without protecting team capacity. Our April Comm Convo focuses...
5 days ago • 1 min read
Hi! I recently came across a line from Microsoft CCO Frank X. Shaw that articulated a challenge we biopharma communicators face every day: The pressure to treat everything like it can’t wait. In one of his weekly TGIF emails, Shaw wrote: "I think we generally have more time to make sure we get something right than we allow ourselves. I am reminded it is never too late to make a better decision. And that we rarely have to accomplish everything all at once… we can win more slowly, which is...
7 days ago • 2 min read
Hi! T2B's Investor Relations Roundtable is adding three new members for Year 2. If you work at the intersection of IR and corporate comms — whether that's your primary focus or part of a broader role — we invite you to consider applying. About the roundtable Chaired by Deborah Elson, Senior Director, Corporate Communications and Investor Relations at Tonix Pharmaceuticals, the roundtable is a small working group focused on advancing IR practice across the biopharma industry. Returning members...
11 days ago • 1 min read
T2B Monthly | March 2026 Hi! The work feels especially layered right now, and so do the conversations happening across T2B. This month’s newsletter pulls together a few of the areas where communicators are being asked to bring judgment, steadiness, and stronger partnership. And if you’re in Boston or NY/NJ, I hope to see you at our rescheduled mixers tonight and tomorrow! Details below. Today's email is 2,017 words, a 7-minute read. In This Edition 🗓️ T2B programming snapshot 🎥 ICYMI: Recent...
13 days ago • 8 min read
Hi! Regardless if you’re a solopreneur, agency founder or leader, or in-house practitioner, knowing the business of the business is table stakes for us communicators. Powerhouse Andrea Johnston will join us to share lessons from her 30+ years of experience spanning corporate, agency, and entrepreneurship. As many of you know, Andrea built Pure Communications, growing it from a one-woman firm in 2004 into a leading biotech and pharma marketing partner before its acquisition by W2O Group (now...
14 days ago • 1 min read
Hi! While our field has its own regulatory, scientific, and stakeholder complexities, many of the judgment calls we face around trust, executive counsel, reputation, and change aren’t unique to biotech. Communicators in other highly scrutinized sectors often navigate similar pressures, often with lessons that translate in useful ways. Tomorrow’s Comm Convo brings together communications leaders who have worked both inside and outside of biopharma. They’ll share how working in other industries...
19 days ago • 1 min read
Hi, and Happy Friday! At our Q1 IR Roundtable event, How ESG Drives Trust Among Investors and Patients Alike, our guest speakers dug into ESG with a biopharma lens, exploring how we can approach ESG in a way that strengthens credibility. ESG is most effective when it helps stakeholders understand how a company manages risk and makes decisions, rather than being positioned as a separate corporate responsibility exercise. If you weren’t able to join us live, T2B Pro and Student members can...
24 days ago • 2 min read
Hi! At our very first Patient Advocacy & Engagement Roundtable discussion, Patient Stories Without a Fixed Address, the conversation with leaders from Astellas, Bayer, and Atrium Therapeutics focused on what patient centricity looks like when it is treated as a strategic business priority. A consistent theme emerged: Organizations that build strong patient relationships tend to do so by embedding patient perspectives early, operationalizing what they hear, and protecting the integrity of the...
27 days ago • 1 min read